# Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

> **NCT05733312** · NA · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 6 (estimated)

## Conditions studied

- Brain Tumor

## Interventions

- **DEVICE:** InSightec's ExAblate Neuro Model 4000 Type 2.0 (220 KHz) system

## Key facts

- **NCT ID:** NCT05733312
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-24
- **Primary completion:** 2027-01-15
- **Final completion:** 2027-01-15
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05733312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05733312, "Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05733312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*